6 results
Primary Study Objective:To assess the efficacy and safety of the co-administration of low-dose pegvisomant (40 mg, administered via subcutaneous injection given once a week) and long-acting somatostatin analogs (administered once monthly) on the…
The primary study objective is to assess the proportion of patients who remain within the IGF-I age adjusted normal limits with pasireotide LAR (60 mg) monotherapy, after 24 weeks of treatment.Secondary study objectives are assessment of the…
Main objective: To assess the effect of CK-2127107 versus placebo on respiratory function in patients with ALS.
To assess the long-term safety and tolerability of reldesemtiv in patients with ALS
Primary Objective: To establish the effectiveness of lavage with needle arthroscopy in patients with suspected bacterial arthritis of a native joint. The primary outcome measure is the number of additional invasive interventions -needle aspiration,…
The purpose of this study is to evaluate whether the new drug reldesemtiv is effective and safe in patients with ALS. The primary objective is to assess the effect of reldesemtiv versus placebo on functional outcomes in ALS.The secondary objectives…